Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology

Drugs

Volumn 56, Issue 4, 1998, Pages 523-535

  De Groot, A N J A ^a   Van Dongen, P W J ^a   Vree, T B ^a   Hekster, Y A ^a   Van Roosmalen, J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; ERGOMETRINE; ERGOT ALKALOID; METHYLERGOMETRINE; OXYTOCIC AGENT; OXYTOCIN; PROSTAGLANDIN; UTEROTONIC AGENT;

CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG STABILITY; DRUG STORAGE; FEMALE; GYNECOLOGY; HUMAN; INDUCED ABORTION; LABOR; LACTATION INHIBITION; META ANALYSIS; OBSTETRIC HEMORRHAGE; OBSTETRICS; PROPHYLAXIS; REVIEW; SIDE EFFECT; VASOCONSTRICTION;

ERGONOVINE; ERGOT ALKALOIDS; FEMALE; HUMANS; METHYLERGONOVINE; OXYTOCICS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0031737322     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199856040-00002     Document Type: Review

References (77)